Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Toxins|July 26, 2024
General ADP-Ribosylation Mechanism Based on the Structure of ADP-Ribosyltransferase-Substrate ComplexesHideaki Tsuge, Noriyuki Habuka, Toru YoshidaBiochimica Et Biophysica Acta|November 14, 2002
The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymeraseTsuyoshi Adachi, Hideo Ago, Noriyuki Habuka, et al.Toxins|December 24, 2025
Structure of Ribosome-Inactivating Protein from <i>Mirabilis jalapa</i> and Its L12-Stalk-Dependent Inhibition of <i>Escherichia coli</i> RibosomeNanami Nishida, Yuki Ninomiya, Toru Yoshida, et al.Healthcare (Basel, Switzerland)|February 25, 2023
Medication Adherence of People Living with HIV in Japan-A Cross-Sectional StudyYoji Inoue, Shinichi Oka, Seiji Yokoyama, et al.Journal of Medicinal Chemistry|March 24, 2012
Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket bindersYouichi Kawakita, Hiroshi Banno, Tomohiro Ohashi, et al.Bioorganic & Medicinal Chemistry|April 30, 2017
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidateKatsuji Aikawa, Moriteru Asano, Koji Ono, et al.The Journal of Biological Chemistry|April 2, 2011
Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 proteinKathleen Aertgeerts, Robert Skene, Jason Yano, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2017
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivativesMoriteru Asano, Takenori Hitaka, Takashi Imada, et al.Journal of Medicinal Chemistry|October 19, 2011
Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffoldTomoyasu Ishikawa, Masaki Seto, Hiroshi Banno, et al.Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.Pageof 2